{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T20:52:50Z","timestamp":1787863970962,"version":"build-2784847793"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T00:00:00Z","timestamp":1758067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T00:00:00Z","timestamp":1758067200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Intensive Care Med"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1007\/s00134-025-08104-8","type":"journal-article","created":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T13:07:23Z","timestamp":1758114443000},"page":"1775-1783","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Heterogeneity in the response to a high vs low mean arterial pressure target in patients with septic shock a post hoc analysis of a randomized controlled trial"],"prefix":"10.1007","volume":"51","clinical-trial-number":[{"clinical-trial-number":"nct01149278","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Romain","family":"Pirracchio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Fong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9788-5316","authenticated-orcid":false,"given":"Matthieu","family":"Legrand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,17]]},"reference":[{"key":"8104_CR1","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1007\/s00134-021-06506-y","volume":"47","author":"L Evans","year":"2021","unstructured":"Evans L, Rhodes A, Alhazzani W et al (2021) Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021. Intensive Care Med 47:1181\u20131247. https:\/\/doi.org\/10.1007\/s00134-021-06506-y","journal-title":"Intensive Care Med"},{"key":"8104_CR2","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-019-05544-x","author":"D De Backer","year":"2019","unstructured":"De Backer D, Cecconi M, Lipman J et al (2019) Challenges in the management of septic shock: a narrative review. Intensive Care Med. https:\/\/doi.org\/10.1007\/s00134-019-05544-x","journal-title":"Intensive Care Med"},{"key":"8104_CR3","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1056\/NEJMoa1312173","volume":"370","author":"P Asfar","year":"2014","unstructured":"Asfar P, Meziani F, Hamel J-F et al (2014) High versus low blood-pressure target in patients with septic shock. N Engl J Med 370:1583\u20131593. https:\/\/doi.org\/10.1056\/NEJMoa1312173","journal-title":"N Engl J Med"},{"key":"8104_CR4","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1097\/ALN.0000000000004958","volume":"140","author":"E Antonucci","year":"2024","unstructured":"Antonucci E, Garcia B, Legrand M (2024) Hemodynamic support in sepsis. Anesthesiology 140:1205\u20131220. https:\/\/doi.org\/10.1097\/ALN.0000000000004958","journal-title":"Anesthesiology"},{"key":"8104_CR5","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1186\/s13054-024-04877-4","volume":"28","author":"M Legrand","year":"2024","unstructured":"Legrand M, Bagshaw SM, Bhatraju PK et al (2024) Sepsis-associated acute kidney injury: recent advances in enrichment strategies, sub-phenotyping and clinical trials. Crit Care 28:92. https:\/\/doi.org\/10.1186\/s13054-024-04877-4","journal-title":"Crit Care"},{"key":"8104_CR6","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1164\/rccm.202004-1124ED","volume":"202","author":"JA Russell","year":"2020","unstructured":"Russell JA (2020) Personalized blood pressure targets in shock: what if your normal blood pressure is \u201clow\u201d? Am J Respir Crit Care Med 202:10\u201312. https:\/\/doi.org\/10.1164\/rccm.202004-1124ED","journal-title":"Am J Respir Crit Care Med"},{"key":"8104_CR7","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1186\/s13054-022-04255-y","volume":"26","author":"D De Backer","year":"2022","unstructured":"De Backer D, Cecconi M, Chew MS et al (2022) A plea for personalization of the hemodynamic management of septic shock. Crit Care 26:372. https:\/\/doi.org\/10.1186\/s13054-022-04255-y","journal-title":"Crit Care"},{"key":"8104_CR8","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.29050","volume":"3","author":"R Pirracchio","year":"2020","unstructured":"Pirracchio R, Hubbard A, Sprung CL et al (2020) Assessment of machine learning to estimate the individual treatment effect of corticosteroids in septic shock. JAMA Netw Open 3:e2029050. https:\/\/doi.org\/10.1001\/jamanetworkopen.2020.29050","journal-title":"JAMA Netw Open"},{"key":"8104_CR9","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1111\/rssb.12124","volume":"78","author":"P Ding","year":"2016","unstructured":"Ding P, Feller A, Miratrix L (2016) Randomization inference for treatment effect variation. J R Stat Soc Ser B (Stat Methodol) 78:655\u2013671","journal-title":"J R Stat Soc Ser B (Stat Methodol)"},{"key":"8104_CR10","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1353\/obs.2019.0001","volume":"5","author":"S Athey","year":"2019","unstructured":"Athey S, Wager S (2019) Estimating treatment effects with causal forests: an application. Obs Stud 5:37\u201351. https:\/\/doi.org\/10.1353\/obs.2019.0001","journal-title":"Obs Stud"},{"key":"8104_CR11","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1007\/s00134-011-2163-y","volume":"37","author":"H Ait-Oufella","year":"2011","unstructured":"Ait-Oufella H, Lemoinne S, Boelle PY et al (2011) Mottling score predicts survival in septic shock. Intensive Care Med 37:801\u2013807. https:\/\/doi.org\/10.1007\/s00134-011-2163-y","journal-title":"Intensive Care Med"},{"key":"8104_CR12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/kisup.2012.1","volume":"2","author":"Kidney Disease: Improving Global Outcome (KDIGO) Acute Kidney Injury Work Group","year":"2012","unstructured":"Kidney Disease: Improving Global Outcome (KDIGO) Acute Kidney Injury Work Group (2012) KDIGO clinical practice guideline for acute kidney injury. Kidney Int Suppl 2:1\u2013138","journal-title":"Kidney Int Suppl"},{"key":"8104_CR13","doi-asserted-by":"publisher","first-page":"35","DOI":"10.7326\/M18-3667","volume":"172","author":"DM Kent","year":"2020","unstructured":"Kent DM, Paulus JK, van Klaveren D et al (2020) The predictive approaches to treatment effect heterogeneity (PATH) statement. Ann Intern Med 172:35\u201345. https:\/\/doi.org\/10.7326\/M18-3667","journal-title":"Ann Intern Med"},{"key":"8104_CR14","doi-asserted-by":"publisher","first-page":"2957","DOI":"10.1001\/jama.1993.03510240069035","volume":"270","author":"JR Le Gall","year":"1993","unstructured":"Le Gall JR, Lemeshow S, Saulnier F (1993) A new simplified acute physiology score (SAPS II) based on a European\/North American multicenter study. JAMA 270:2957\u20132963","journal-title":"JAMA"},{"key":"8104_CR15","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1007\/BF01709751","volume":"22","author":"JL Vincent","year":"1996","unstructured":"Vincent JL, Moreno R, Takala J et al (1996) The SOFA (sepsis-related organ failure assessment) score to describe organ dysfunction\/failure. on behalf of the working group on sepsis-related problems of the European society of intensive care medicine. Intensive Care Med 22:707\u2013710","journal-title":"Intensive Care Med"},{"key":"8104_CR16","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1080\/01621459.2017.1407322","volume":"114","author":"P Ding","year":"2019","unstructured":"Ding P, Feller A, Miratrix L (2019) Decomposing treatment effect variation. J Am Stat Assoc 114:304\u2013317. https:\/\/doi.org\/10.1080\/01621459.2017.1407322","journal-title":"J Am Stat Assoc"},{"key":"8104_CR17","unstructured":"Velentgas P, Dreyer NA, Nourjah P, et al (2013). Developing a protocol for observational comparative effectiveness research: a user\u2019s guide. Agency for healthcare research and quality (US), Rockville (MD)"},{"key":"8104_CR18","unstructured":"Ding P, Feller A, Fifield B, Miratrix L (2023). Fisherian and Neymanian methods for detecting and measuring treatment effect variation (Version 0.1.3) [R package]"},{"key":"8104_CR19","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1515\/ijb-2019-0088","volume":"17","author":"A J\u00e9rolon","year":"2020","unstructured":"J\u00e9rolon A, Baglietto L, Birmel\u00e9 E et al (2020) Causal mediation analysis in presence of multiple mediators uncausally related. Int J Biostat 17:191\u2013221. https:\/\/doi.org\/10.1515\/ijb-2019-0088","journal-title":"Int J Biostat"},{"key":"8104_CR20","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1007\/s00134-010-2057-4","volume":"37","author":"B Redfors","year":"2011","unstructured":"Redfors B, Bragadottir G, Sellgren J et al (2011) Effects of norepinephrine on renal perfusion, filtration and oxygenation in vasodilatory shock and acute kidney injury. Intensive Care Med 37:60\u201367. https:\/\/doi.org\/10.1007\/s00134-010-2057-4","journal-title":"Intensive Care Med"},{"key":"8104_CR21","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1007\/s00134-007-0665-4","volume":"33","author":"S Deruddre","year":"2007","unstructured":"Deruddre S, Cheisson G, Mazoit J-X et al (2007) Renal arterial resistance in septic shock: effects of increasing mean arterial pressure with norepinephrine on the renal resistive index assessed with Doppler ultrasonography. Intensive Care Med 33:1557\u20131562. https:\/\/doi.org\/10.1007\/s00134-007-0665-4","journal-title":"Intensive Care Med"},{"key":"8104_CR22","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1164\/ajrccm.159.4.9802055","volume":"159","author":"R Bellomo","year":"1999","unstructured":"Bellomo R, Kellum JA, Wisniewski SR, Pinsky MR (1999) Effects of norepinephrine on the renal vasculature in normal and endotoxemic dogs. Am J Respir Crit Care Med 159:1186\u20131192. https:\/\/doi.org\/10.1164\/ajrccm.159.4.9802055","journal-title":"Am J Respir Crit Care Med"},{"key":"8104_CR23","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.1007\/s00134-007-0734-8","volume":"33","author":"C Langenberg","year":"2007","unstructured":"Langenberg C, Wan L, Egi M et al (2007) Renal blood flow and function during recovery from experimental septic acute kidney injury. Intensive Care Med 33:1614\u20131618. https:\/\/doi.org\/10.1007\/s00134-007-0734-8","journal-title":"Intensive Care Med"},{"key":"8104_CR24","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1001\/jama.2020.0930","volume":"323","author":"F Lamontagne","year":"2020","unstructured":"Lamontagne F, Richards-Belle A, Thomas K et al (2020) Effect of reduced exposure to vasopressors on 90-day mortality in older critically Ill patients with vasodilatory hypotension: a randomized clinical trial. JAMA 323:938\u2013949. https:\/\/doi.org\/10.1001\/jama.2020.0930","journal-title":"JAMA"},{"key":"8104_CR25","doi-asserted-by":"publisher","first-page":"EVIDoa2400359","DOI":"10.1056\/EVIDoa2400359","volume":"4","author":"F Angriman","year":"2025","unstructured":"Angriman F, Momenzade N, Adhikari NKJ et al (2025) Blood pressure targets for adults with vasodilatory shock - an individual patient data meta-analysis. NEJM Evid 4:EVIDoa2400359. https:\/\/doi.org\/10.1056\/EVIDoa2400359","journal-title":"NEJM Evid"},{"key":"8104_CR26","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1007\/s00134-025-07910-4","volume":"51","author":"A Endo","year":"2025","unstructured":"Endo A, Yamakawa K, Tagami T et al (2025) Efficacy of targeting high mean arterial pressure for older patients with septic shock (OPTPRESS): a multicentre, pragmatic, open-label, randomised controlled trial. Intensive Care Med 51:883\u2013892. https:\/\/doi.org\/10.1007\/s00134-025-07910-4","journal-title":"Intensive Care Med"},{"key":"8104_CR27","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/s13054-022-03911-7","volume":"26","author":"PM Wieruszewski","year":"2022","unstructured":"Wieruszewski PM, Khanna AK (2022) Vasopressor choice and timing in vasodilatory shock. Crit Care 26:76. https:\/\/doi.org\/10.1186\/s13054-022-03911-7","journal-title":"Crit Care"},{"key":"8104_CR28","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1007\/s00134-022-06708-y","volume":"48","author":"M Legrand","year":"2022","unstructured":"Legrand M, Zarbock A (2022) Ten tips to optimize vasopressors use in the critically ill patient with hypotension. Intensive Care Med 48:736\u2013739. https:\/\/doi.org\/10.1007\/s00134-022-06708-y","journal-title":"Intensive Care Med"},{"key":"8104_CR29","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.1001\/jama.2025.3046","volume":"333","author":"A Kalimouttou","year":"2025","unstructured":"Kalimouttou A, Kennedy JN, Feng J et al (2025) Optimal vasopressin initiation in septic shock: the OVISS reinforcement learning study. JAMA 333:1688\u20131698. https:\/\/doi.org\/10.1001\/jama.2025.3046","journal-title":"JAMA"},{"key":"8104_CR30","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1704154","author":"A Khanna","year":"2017","unstructured":"Khanna A, English SW, Wang XS et al (2017) Angiotensin II for the treatment of vasodilatory shock. N Engl J Med. https:\/\/doi.org\/10.1056\/NEJMoa1704154","journal-title":"N Engl J Med"},{"key":"8104_CR31","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1186\/s13054-024-05123-7","volume":"28","author":"M Legrand","year":"2024","unstructured":"Legrand M, Khanna AK, Ostermann M et al (2024) The renin-angiotensin-aldosterone-system in sepsis and its clinical modulation with exogenous angiotensin II. Crit Care 28:389. https:\/\/doi.org\/10.1186\/s13054-024-05123-7","journal-title":"Crit Care"}],"container-title":["Intensive Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00134-025-08104-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00134-025-08104-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00134-025-08104-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T22:02:47Z","timestamp":1759874567000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00134-025-08104-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,17]]},"references-count":31,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["8104"],"URL":"https:\/\/doi.org\/10.1007\/s00134-025-08104-8","relation":{},"ISSN":["0342-4642","1432-1238"],"issn-type":[{"value":"0342-4642","type":"print"},{"value":"1432-1238","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,17]]},"assertion":[{"value":"12 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"RP is a Section Editor for Intensive Care Medicine. He has not taken part in the review or selection process of this article. RP is supproted by grants PCORI: ME-2022C1-25619; DOD: P0575392; NIH R01: R01EB035028 & R01HL178952; AOP Health research grant: A144424. NF has no conflict of interest. ML is supported by grants R0GM15149401 and R01DK13948401 from the National Institutes of Health and received personal fees from Viatris, Alexion, Pharmazz Inc, and Radiometer.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}